# Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia

> **NCT03182465** · NA · TERMINATED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 54 (actual)

## Conditions studied

- Febrile Neutropenia, Drug-Induced

## Interventions

- **DIAGNOSTIC_TEST:** Value of ProCalcitonin

## Key facts

- **NCT ID:** NCT03182465
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-04
- **Primary completion:** 2022-12-25
- **Final completion:** 2022-12-25
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182465, "Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03182465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
